Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid. [electronic resource]
- The international journal of biochemistry & cell biology Dec 2015
- 142-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-5875
10.1016/j.biocel.2015.10.023 doi
Animals Aorta--metabolism Atherosclerosis--drug therapy Cells, Cultured Diet, High-Fat--adverse effects Drug Evaluation, Preclinical Gene Expression Heme Oxygenase-1--metabolism Human Umbilical Vein Endothelial Cells--drug effects Humans Lipoproteins, LDL--physiology Male NADPH Oxidases--metabolism NF-E2-Related Factor 2--metabolism Oleanolic Acid--pharmacology Protein Subunits--metabolism Quail Reactive Oxygen Species--metabolism Scavenger Receptors, Class E--genetics